New #BreastCancer research funding is open from @ConquerCancerFd! Whether you're launching an independent lab, leading original trials, or mentoring future leaders, 3 new global grants are accepting submissions.
🌍 U.S. & Global applicants welcome: bit.ly/3UXTuPS
🌍 U.S. & Global applicants welcome: bit.ly/3UXTuPS
1
0
3
1,109
ASCO retweeted
Great perspective from @PauloBergerot in @ASCO Daily News on a critical challenge in #ExerciseOncology: moving beyond the optimal exercise dose to interventions that are feasible, accessible, and sustainable in patients’ everyday lives #ASCOQLTY26
dailynews.ascopubs.org/do/can-exercis…
dailynews.ascopubs.org/do/can-exercis…
1
7
27
2,053
Time is running out to share your story on the #ASCO27 stage! How did a patient’s journey look before your team stepped in & what changed after you collaborated? Inspire others by sharing your perspective on teamwork.
Audition for ASCO Voices by Nov 13: bit.ly/4hCwYTP
Audition for ASCO Voices by Nov 13: bit.ly/4hCwYTP
0
1
6
1,026
Last week, we released a new Living Guideline for treating HR+, HER2-negative stage I-III #breastcancer, with recommendations for individualized care based on genomics, patient preferences, and estimated risk. Read a brief analysis from #ASCODailyNews: bit.ly/4BFJR92
0
3
6
1,340
Join colleagues across specialties at the 2027 Multidisciplinary Head and Neck Cancers Symposium in Orlando from Feb. 25-27! We are a proud co-sponsor of this meeting w/ @ASTRO_org.
Register by Jan. 15 for the best rates: bit.ly/4jbpUA3
#MHNCS27
Register by Jan. 15 for the best rates: bit.ly/4jbpUA3
#MHNCS27
0
7
10
1,663
ASCO retweeted
Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today!
Due Dec. 10th: bit.ly/47b42hb
Due Dec. 10th: bit.ly/47b42hb
0
5
10
2,027
Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today!
Due Dec. 10th: bit.ly/47b42hb
Due Dec. 10th: bit.ly/47b42hb
0
5
10
2,027
TIME IS RUNNING OUT! 🚨
Proposals for ASCO's 2027 International Palliative Care Education Collaboration must be submitted by November 30, 2026. Don't miss this multi-year opportunity to empower local palliative care champions.
Apply: bit.ly/4jD8Rap
#ASCOGlobalImpact
Proposals for ASCO's 2027 International Palliative Care Education Collaboration must be submitted by November 30, 2026. Don't miss this multi-year opportunity to empower local palliative care champions.
Apply: bit.ly/4jD8Rap
#ASCOGlobalImpact
0
1
1
1,277
ASCO retweeted
Want to learn more about the science presented at #ASCOQLTY26 ? 🎧 Highly recommend this @ASCO podcast with @montypal and @RyanNipp!
Especially loved their discussion of @PauloBergerot’s study (Abstract 487) showing how remote exercise improves QoL, with fatigue reduction as a /t.co/trT2gSg8Xv
Especially loved their discussion of @PauloBergerot’s study (Abstract 487) showing how remote exercise improves QoL, with fatigue reduction as a /t.co/trT2gSg8Xv
0
8
18
1,562
Dr. @QuantumOnc examines how fellows in an Indian training context can translate their feedback from the ASCO Medical Oncology In-Training Examination (MedOnc ITE) into a focused, realistic, 6-month study plan.
Read more: bit.ly/3WQ333K
#ASCOConnection
Read more: bit.ly/3WQ333K
#ASCOConnection
0
1
5
1,698
Have you made your voting plan for the U.S. General Election? Remind your colleagues to do the same by reposting this image! Still need to make your plan?
Visit bit.ly/4Br01Ty
#ASCOAdvocacy
Visit bit.ly/4Br01Ty
#ASCOAdvocacy
0
0
3
1,478
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.
Learn more about FASCO distinction: bit.ly/4BvJVrG
Learn more about FASCO distinction: bit.ly/4BvJVrG
3
20
86
27,071
New Living Guideline: Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I - III Breast Cancer. The new Living Guideline covers the use of medical therapies for stage I-III hormone receptor-positive, HER2-negative breast cancer. Learn more: bit.ly/4ewVF3o
0
5
4
1,894
🎙 @montypal of @cityofhope and @RyanNipp of @StephensonCC
discuss high-impact research presented at #ASCOQLTY26 on the latest episode of the #ASCODailyNews Podcast: bit.ly/4zg53kt
discuss high-impact research presented at #ASCOQLTY26 on the latest episode of the #ASCODailyNews Podcast: bit.ly/4zg53kt
0
9
24
3,027
And the answer was ... D! Erdafitinib causes ocular toxicity; a baseline ophthalmic exam is required. Did you get it right? Let us know in the comments!
Subscribe to ASCO-SEP® today: bit.ly/4syBUOX
ASCO members get 20% off; additional discounts available.
Subscribe to ASCO-SEP® today: bit.ly/4syBUOX
ASCO members get 20% off; additional discounts available.
Test your clinical knowledge with a ❓ from our ASCO-SEP Question Bank!
Q: Patient (72) starts a TKI for FGFR3-altered urothelial cancer. Next step?
0
0
0
1,525
Want to learn how the updated ICH E6(R3) guidelines can cut trial bureaucracy and speed up cancer research?
Join ASCO and @myESMO for a joint webinar on November 2, 2026, exploring collaborative solutions to strengthen clinical trials.
Register now: bit.ly/4isxS60
Join ASCO and @myESMO for a joint webinar on November 2, 2026, exploring collaborative solutions to strengthen clinical trials.
Register now: bit.ly/4isxS60
👉 How can collaboration help reduce unnecessary complexity in clinical research? Join a discussion on how cross-stakeholder collaboration can help create a more sustainable, effective research environment
🔗Register now: ow.ly/eCgF50ZZn0c
#ESMOWebinar
@FAndreMD @TeresaSAmaral @ASCO
0
1
3
1,546
Voting in the ASCO Election is open now until December 2! Meet the candidate for President-Elect, @teekayowo MD, PhD, FASCO.
Learn more about Dr. Owonikoko and make your voice heard: bit.ly/4zi4KWm
Learn more about Dr. Owonikoko and make your voice heard: bit.ly/4zi4KWm
3
17
47
9,211
Unnecessary administrative burden shouldn't stand between patients & progress.
ASCO & @myESMO have issued a new joint consensus statement in @jco_oa & @ESMO_Open exploring how updated ICH E6(R3) guidelines can help streamline clinical trials.
Read more: bit.ly/4ijgGj9
ASCO & @myESMO have issued a new joint consensus statement in @jco_oa & @ESMO_Open exploring how updated ICH E6(R3) guidelines can help streamline clinical trials.
Read more: bit.ly/4ijgGj9
1
11
18
3,159
We agree with @DrDespina123: in addition to the research, one of the best parts of a meeting is coming together & connecting. Join us at #GI27 to build meaningful global relationships that will shape the future of GI cancer patient care: bit.ly/4zSkoaH
Some of the most impactful moments @ASCO #GI26 happen between sessions—connecting with collaborators, colleagues, and shaping what comes next.
Grateful to connect with #kras, #ctdna, #immunotherapy #collaborators moving research forward
#TeamScience #GIOncology #Collaboration
1
1
6
2,953